These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease. Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline as Add-On Treatment to Donepezil in Copper Sulphate-Induced Alzheimer's Disease-Like Neurodegeneration in Rats. Elseweidy MM; Mahrous M; Ali SI; Shaheen MA; Younis NN Neurotox Res; 2023 Dec; 41(6):546-558. PubMed ID: 37821782 [TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors. Tayeb HO; Yang HD; Price BH; Tarazi FI Pharmacol Ther; 2012 Apr; 134(1):8-25. PubMed ID: 22198801 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's Disease Therapeutic Approaches. Revi M Adv Exp Med Biol; 2020; 1195():105-116. PubMed ID: 32468465 [TBL] [Abstract][Full Text] [Related]
13. An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects. Sharma P; Singh M Life Sci; 2023 May; 320():121568. PubMed ID: 36925061 [TBL] [Abstract][Full Text] [Related]
14. A review on Alzheimer's disease pathophysiology and its management: an update. Kumar A; Singh A; Ekavali Pharmacol Rep; 2015 Apr; 67(2):195-203. PubMed ID: 25712639 [TBL] [Abstract][Full Text] [Related]
15. What is the rationale for new treatment strategies in Alzheimer's disease? Rogawski MA CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease. León R; Garcia AG; Marco-Contelles J Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014 [TBL] [Abstract][Full Text] [Related]
18. Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition. Das S; Sengupta S; Chakraborty S ACS Chem Neurosci; 2020 Nov; 11(21):3510-3522. PubMed ID: 33073981 [TBL] [Abstract][Full Text] [Related]
19. Carbamate as a potential anti-Alzheimer's pharmacophore: A review. Singh YP; Kumar N; Chauhan BS; Garg P Drug Dev Res; 2023 Dec; 84(8):1624-1651. PubMed ID: 37694498 [TBL] [Abstract][Full Text] [Related]
20. [Anti-dementia drugs for Alzheimer disease in present and future]. Nabeshima T; Noda Y; Kamei H Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):24P-29P. PubMed ID: 12491771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]